SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Alinovi R., Vettori M.V., Mutti A., Cavazzini S., Bacchini A., Bergamaschi E. (1996) Dopamine (DA) metabolism in PC12 cells exposed to manganese (Mn) at different oxidation states. Neurotoxicology 17,743750.
  • 2
    Anglade P., Vyas S., Javoy-Agid F., Herrero M.T., Michel P.P., Marquez J., Mouatt-Prigent A., Ruberg M., Hirsch E.C., Agid Y. (1997) Apoptosis and autophagy in nigral neurons of patients with Parkinson’s disease. Histol. Histopathol.12,2531.
  • 3
    Banati R.B., Daniel S.E., Blunt S.B. (1998) Glial pathology but absence of apoptotic nigral neurons in long-standing Parkinson’s disease. Mov. Disord. 13,221227.
  • 4
    Basma A.N., Morris E.J., Nicklas W.J., Geller M.H. (1995) L-DOPA cytotoxicity to PC12 cells in culture is via its autoxidation. J. Neurochem. 64,825832.
  • 5
    Desole M.S., Esposito G., Migheli R., Fresu L., Sircana S., Zangani D., Miele M., Miele E. (1995) Cellular defence mechanisms in the striatum and of young and aged rats subchronicallyl exposed to manganese. Neuropharmacology 34,298305.
  • 6
    Desole M.S., Esposito G., Migheli R., Sircana S., Delogu M.R., Fresu L., Miele M., De Natale G., Miele E. (1997a) Glutathione deficiency potentiates manganese toxicity in rat striatum and brainstem and in PC12 cells. Pharmacol. Res. 36,285292.
  • 7
    Desole M.S., Sciola L., Delogu M.R., Sircana S., Migheli R., Miele E. (1997b) Manganese and 1-methyl-4-(2′-ethylphenyl)-1,2,3,6-tetrahydropyridine-induced apoptosis in PC12 cells : role of oxidative stress. Neurochem. Int. 31,169176.
  • 8
    Donaldson J. (1987) The physiopathological significance of manganese in brain : its relation to schizophrenia and neurodegenerative disorders. Neurotoxicology 8,451462.
  • 9
    Florence T.M. & Stauber J.L. (1989) Manganese catalysis of dopamine oxidation. Sci. Total Environ. 78,233240.
  • 10
    Galvani P., Fumagalli P., Santagostino A. (1995) Vulnerability of mitochondrial complex I in PC12 cells exposed to manganese. Eur. J. Pharmacol. 293,377383.
  • 11
    Gavin C.E., Gunter K.K., Gunter T.E. (1992) Mn2+ sequestration by mitochondria and inhibition of oxidative phosphorylation. Toxicol. Appl. Pharmacol. 115,15.
  • 12
    Graham D.G. (1984) Catecholamine toxicity : a proposal for the molecular pathogenesis of manganese neurotoxicity and Parkinson’s disease. Neurotoxicology 5,113118.
  • 13
    Haber F. & Weiss J. (1934) The catalytic decomposition of H2O2 by iron salts. Proc. R. Soc. Lond. [A] 147,332351.
  • 14
    Halliwell B. (1992) Reactive oxygen species and the central nervous system. J. Neurochem. 59,16091623.
  • 15
    Han S.K. & Cohen G. (1996) Inhibition of catalase in mesencephalic culture by L-DOPA and dopamine. Neurochem. Int. 29,645649.
  • 16
    Hartley A., Stone J.M., Heron C., Cooper J.M., Schapira A.H.V. (1994) Complex I inhibitors induce dose-dependent apoptosis in PC12 cells : relevance to Parkinson’s disease. J. Neurochem. 63,19871990.
  • 17
    Hastings T.G., Lewis D.A., Zigmond M.J. (1996) Role of oxidative stress in the neurotoxic effects of intrastriatal dopamine injections. Proc. Natl. Acad. Sci. USA 93,10561061.
  • 18
    Hirata Y., Adachi K., Kiuchi K. (1998) Activation of JNK pathways and induction of apoptosis by manganese in PC12 cells. J. Neurochem. 71,16071615.
  • 19
    Jellinger K. (1999) The role of iron in neurodegeneration. Prospect for pharmacotherapy of Parkinson’s disease. Drugs Aging 14,115140.
  • 20
    Klegeris A., Korkina L.G., Greenfeld S.A. (1995) Autoxidation of dopamine : a comparison of luminescence and spectrophotometric detection in basic solutions. Free Radic. Biol. Med. 18,215222.
  • 21
    Lai C.T. & Yu P.H. (1997) Dopamine and L-β-3,4-dihydroxyphenylalanine hydrochloride (L-DOPA)-induced cytotoxicity towards catecholaminergic neuroblastoma SH-SY5Y cells. Effects of oxidative stress and antioxidative factors. Biochem. Pharmacol. 53,363372.
  • 22
    Liccione J.J. & Maines M.D. (1988) Selective vulnerability of glutathione metabolism and cellular defense mechanism in rat striatum to manganese. J. Pharmacol. Exp. Ther. 247,156161.
  • 23
    Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193,265275.
  • 24
    Miller D.M., Buettner G.R., Aust S.D. (1990) Transition metals as catalysts of “autoxidation” reactions. Free Radic. Biol. Med. 18,215222.
  • 25
    Mochizuki H., Goto K., Mori H., Mizuno Y. (1996) Histochemical detection of apoptosis in Parkinson’s disease. J. Neurol. Sci. 137,120123.
  • 26
    Nakao N., Nakai K., Itakura T. (1997) Metabolic inhibition enhances selective toxicity of L-DOPA toward mesencephalic dopamine neurons in vitro. Brain Res. 777,202209.
  • 27
    Pardo B., Mena M.A., Casajeros M.J., Paino C.L., De Yebenes J.G. (1995) Toxic effects of L-DOPA on mesencephalic cell cultures : protection with antioxidant. Brain Res. 682,133143.
  • 28
    Parenti M., Flauto C., Parati E., Vescovi A., Groppetti A. (1986) Manganese neurotoxicity : effects of L-DOPA and pargyline treatments. Brain Res. 367,813.
  • 29
    Parsons P.G. (1985) Modification of dopa toxicity in human tumour cells. Biochem. Pharmacol. 34,18011807.
  • 30
    Przedborski S., Jackson-Lewis V., Fahn S. (1995) Antiparkinsonian therapies and brain mitochondrial complex I activity. Mov. Disord. 10,312317.
  • 31
    Rabinovich A.D. & Hastings T.G. (1998) Role of endogenous glutathione in the oxidation of dopamine. J. Neurochem. 71,20712078.
  • 32
    Sandstrom P.A., Mannie M.D., Buttke T.H. (1994) Inhibition of activation-induced death in T cell hybridomas by thiol antioxidant : oxidative stress as a mediator of apoptosis. J. Leukocyte Biol. 55,221226.
  • 33
    Seaton T.A., Cooper M.J., Schapira A.H.V. (1997) Free radical scavengers protect dopaminergic cell lines from apoptosis induced by complex I inhibitors. Brain Res. 777,110118.
  • 34
    Shen X.M. & Dryhurst G. (1998) Iron- and manganese-catalyzed autoxidation of dopamine in the presence of L-cysteine : possible insights into iron- and manganese-mediated dopaminergic neurotoxicity. Chem. Res. Toxicol. 11,824837.
  • 35
    Spencer J.P., Jenner A., Aruoma O.I., Evans P.J., Jenner P., Lees A.J., Marsden D.C., Halliwell B. (1994) Intense oxidative DNA damage promoted by L-DOPA and its metabolites. Implications for neurodegenerative diseases. FEBS Lett. 353,246250.
  • 36
    Spencer J.P., Jenner A., Halliwell B. (1995) Superoxide-dependent depletion of reduced glutathione by L-DOPA and dopamine. Relevance to Parkinson’s disease. Neuroreport 6,14801484.
  • 37
    Sun A.Y., Yang W.L., Kim H.D. (1993) Free radical and lipid peroxidation in manganese-induced neuronal cell injury. Ann. NY Acad. Sci. 679,358363.
  • 38
    Walkinshaw G. & Waters C.M. (1995) Induction of apoptosis in catecholaminergic PC12 cells by L-DOPA. Implications for the treatment of Parkinson’s disease. J. Clin. Invest. 95,24582464.
  • 39
    Ziv I., Melamed E., Nardi N., Luria D., Achiron A., Offen D., Barzilai A. (1994) Dopamine induces apoptosis-like cell death in cultured chick sympathetic neurons—a possible novel pathogenetic mechanism in Parkinson’s disease. Neurosci. Lett. 170,136140.
  • 40
    Ziv I., Zilkha-Falb R., Offen D., Shirvan A., Barzilai A., Melamed E. (1997) Levodopa induces apoptosis in cultured neuronal cells : a possible accelerator of nigrostriatal degeneration in Parkinson’s disease ? Mov. Disord. 12,1723.